Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States (2024)

Chapter: Appendix D: Information-Gathering Public Sessions

Previous Chapter: Appendix C: The 2022 Infant Formula Shortage Timelines and Actions
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.

Appendix D

Information-Gathering Public Sessions

This appendix contains the following:

  • D-1: Meeting 3 public session agenda
  • D-2: Meeting 7 public session agenda
  • D-3: Meeting 8 public session agenda
  • D-4: Meeting 9 public session agenda
  • D-5: Meeting 11 public session agenda
  • D-6: Meeting 12 public session agenda
  • D-7: Meeting 13 public session agenda
  • D-8: Meeting 16 public session agenda
  • D-9: Meeting 18 public session agenda
  • D-10: Meeting 19 public session agenda
  • D-11: Meeting 21 public session agenda
  • D-12: Meeting 22 public session agenda
  • D-13: Meeting 24 public session agenda
  • D-14: Meeting 25 public session agenda
  • D-15: Meeting 26 public session agenda

The presentation slides from each public session are available in the Public Access File.

Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.

D-1: Meeting 3 Public Session Agenda
September 28, 2023
1:00 pm – 3:00 pm EST

1:00 pm Opening Remarks
Barbara Schneeman, Committee Chair
Ravi Anupindi, Vice Chair
1:10 pm Sponsor Remarks
  • Patricia Hansen, Deputy Director, Office of Nutrition and Food Labeling (ONFL), Center for Food Safety and Applied Nutrition (CFSAN), FDA
  • Doug Balentine, Senior Science Advisor for International Nutrition Policy, CFSAN, FDA
  • Brad Brown, Senior Scientific Advisor for Economics and Policy, CFSAN, FDA
  • Travis Minor, Senior Science Advisor, CFSAN, FDA
  • Carrie Assar, Team Leader, Infant Formula and Medical Foods Staff, ONFL, CFSAN, FDA
  • Donald Carrington, Senior Program Management Analyst, ONFL, CFSAN, FDA
2:00 pm Questions from Committee
Moderated by Barbara Schneeman, Committee Chair
3:00 pm Adjourn Meeting

D-2: Meeting 7 Public Session Agenda
November 10, 2023
10:00 am – 12:00 pm EST

10:00 am Welcome and Introductions
Barbara Schneeman, Committee Chair
10:05 am Panel Discussion
Moderated by: Barbara Schneeman, Committee Chair
  • Michael B. Montalto, PhD
  • Russell J. Merritt, MD, PhD
  • Jon A. Vanderhoof, MD
  • John C. Wallingford, PhD
12:00 pm Adjourn Meeting
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.

D-3: Meeting 8 Public Session Agenda
November 16, 2023
1:00 pm – 3:00 pm EST
Agenda

1:00 pm Welcome and Chair Statement
Barbara Schneeman, Committee Chair
1:05 pm WIC Panel Discussion—Infant Formula Contracting
  • Sheryl Pickering, Health Services Consultant/WIC Tribal Liaison, Washington State Department of Health
  • Mary Anne Burghardt, Assistant Director for Division of Child and Family Well-Being, Community Nutrition Services Section, North Carolina State Department of Health
  • Kim Lovenduski, North Carolina State Department of Health
2:00 pm WIC Panel Discussion—Challenges and Lessons Learned Providing Infant Formula During the 2022 Shortage
  • Sagrario Nielsen, MS RDN, Deputy Director of Nutrition Services and Projects, PHFE WIC
  • Andrea Urquidez, Nutrition Education and Clinical Services Project Manager, Texas WIC
  • Melody Schrank RDN/LD, WIC Nutrition Education Manager, Chickasaw Nation WIC Program
  • Sheryl Pickering, Health Services Consultant/WIC Tribal Liaison, Washington State Department of Health
3:00 pm Adjourn Meeting

D-4: Meeting 9 Public Session Agenda
November 20, 2023
10:00 am – 11:00 am EST

10:00 am Welcome and Introductions
Barbara Schneeman, Committee Chair
10:05 am Discussion
Moderated by Barbara Schneeman
  • Jose M. Saavedra, M.D.
  • Cynthia Barber, Ph.D.
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
11:00 am Adjourn Meeting

D-5: Meeting 11 Public Session Agenda
November 27, 2023
9:30 am – 11:00 am EST

9:30 am Welcome
Ravi Anupindi, Committee Vice Chair
9:35 am Presentations
  • Seamus Fanning, Ph.D., Full Professor of Food Safety and Zoonoses, Director of Academic Centre—Centre for Food Safety
  • Matthew Wise, Ph.D., Branch Chief, Outbreak Response and Prevention Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention
  • Julia Haston, M.D., EIS Officer, Centers for Disease Control and Prevention
  • Robert Tauxe, M.D., M.P.H., Director, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention
10:30 am Discussion and Committee Questions
Moderated by Ravi Anupindi
11:00 am Adjourn Meeting

D-6: Meeting 12 Public Session Agenda
November 28, 2023
12:00 pm – 1:00 pm EST

12:00 pm Welcome
Kathleen Rasmussen, Committee Member
12:05 pm Timeline Presentation
Sarah Widor, Deputy Associate Administrator for the Supplemental Nutrition and Safety Programs at the Food and Nutrition Service, USDA
12:30 pm Questions from Committee Members
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.

Moderated by Kathleen Rasmussen
  • Sarah Widor, Deputy Associate Administrator, Supplemental Nutrition and Safety Programs at the Food and Nutrition Service, USDA
  • Sara Olson, Chief, Policy Branch, Supplemental Food Programs Division at the Food and Nutrition Service, USDA
  • Kristin Garcia, Division Director, Food Safety & Nutrition, Supplemental Nutrition and Safety Programs at the Food and Nutrition Service, USDA
1:00 pm Adjourn Meeting

D-7: Meeting 13 Public Session Agenda
December 1, 2023
10:00 am – 4:30 pm EST

10:00 am Welcome and Chair Statement
Barbara Schneeman, Committee Chair
10:10 am FDA Roles and Responsibilities
  • Susan Mayne, Former Director, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration
  • Howard Sklamberg, Former Director, Office of Compliance, U.S. Food and Drug Administration
  • Frank Yiannas, Former Deputy Commissioner for Food Policy and Response, U.S. Food and Drug Administration
10:30 am Panel Discussion
Moderated by Marta Wosińska
  • Susan Mayne, Former Director, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration
  • Howard Sklamberg, Former Director, Office of Compliance, U.S. Food and Drug Administration
  • Frank Yiannas, Former Deputy Commissioner for Food Policy and Response, U.S. Food and Drug Administration
  • John Watson, Watson Dairy Consulting
  • Robert Burns, Adjunct Professor of Practice, IU School of Public Health, Bloomington
  • Steven Braun, Former Mead Johnson Employee
11:30 am Overview of Infant Formula Regulatory Differences Between the United States and Europe
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Robert Burns, Adjunct Professor of Practice, Indiana University (IU) School of Public Health, Bloomington
12:00 pm Break
1:30 pm Welcome, Chair Statement, Committee Introductions
Barbara Schneeman, Committee Chair
Moderator: Ravi Anupindi, Committee Member
1:40 pm Overview of How Infant Formula Moves from the Factory to Consumers
Jennifer Hatcher, Chief Public Policy Officer and Senior Vice President, FMI
Health Care Distribution Supply Chain
Mary Byrne, Vice President, Supply Chain, Cardinal Health
Questions: 15 minutes
Moderator: Debbie O’Connor, Committee Member
2:15 pm Panel 2: Hospitals and Special Use
Large hospital – Mayo Clinic (product supply)
  • Amy Conway Quality Value Analysis within Supply Chain Management
  • Scott Marsh, Sr. Value Analyst Portfolio Advisor, Clinical Supply Chain Management
Questions: 10 minutes
Moderator: Ravi Anupindi, Vice Chair
Vizient group purchasing organization (GPO)
  • Kurt Henry, Senior Director, Contract Services, Vizient, Inc
Questions: 10 minutes
Moderator: Ravi Anupindi, Vice Chair
3:00 pm Panel 2b: Hospital Staff Hospitals (customer facing)
  • Andrea Armellino, Pediatric Nutrition Support, Mayo Clinic
  • Whitney Duddey, Clinical Manager for Nutrition Support, at Cincinnati Children’s
  • Stephanie Merlino Barr, Neonatal Nutritionist, MetroHealth System, Cleveland, Ohio
3:30 pm Panel 3: Consumers and Supply Shocks
Moderator: Kadee Russ, Committee Member
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
  • Jennifer M. Canvasser, NEC Society, Founder
  • Sarah Chamberlin, Executive Director, flok Health
  • Jennifer Smilowitz, Assistant Professor of Cooperative Extension, University of California, Davis
  • Shonte’ Terhune-Smith, Health Educator, Lactation Consultant, and Birth Doula practicing in Genesee County
4:30 pm Adjourn Meeting

D-8: Meeting 16 Public Session Agenda
December 15, 2023
9:30 am – 10:00 am EST

9:30 am Welcome and Chair Statement
Barbara Schneeman, Committee Chair
9:35 am Discussion with Stacy Dean
Stacy Dean, Deputy Under Secretary, Food and Nutrition Service, USDA
10:00 am Adjourn Meeting

D-9: Meeting 18 Public Session Agenda
December 19, 2023
1:00 pm – 2:00 pm EST

1:00 pm Welcome and Chair Statement
Barbara Schneeman, Committee Chair
1:05 pm Discussion with Brian Dittmeier and Ali Hard
Moderated by Zoë Neuberger
  • Brian Dittmeier, Former Senior Director of Public Policy, National Women, Infants & Children Association
2:00 pm Adjourn Meeting

D-10: Meeting 19 Public Session Agenda
January 4, 2024
1:30 pm – 2:30 pm EST

Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
1:30 pm Welcome and Chair Statement
Barbara Schneeman, Committee Chair
1:35 pm Discussion with 21 Forward
Moderated by Ravi Anupindi
  • William J. Kassler, M.D., M.P.H., Former Chief Medical Officer, Palantir Technologies
  • Philomena Fritz, Healthcare and Public Health Strategy & Growth, Palantir Technologies
2:30 pm Adjourn Meeting

D-11: Meeting 21 Public Session Agenda
January 19, 2024
12:00 pm – 2:00 pm EST

12:00 pm Welcome and Chair Statement
Barbara Schneeman, Committee Chair
12:05 pm Discussion with Former COVID-19 Supply Chain Coordinator
Moderated by Barbara Schneeman
  • Tim Manning, Former National COVID-19 Supply Chain Coordinator
1:00 pm Discussion with Medicaid
Moderated by Barbara Schneeman
  • Perrie Briskin, Senior Advisor, Center for Medicaid and CHIP Services
2:00 pm Adjourn Meeting

D-12: Meeting 22 Public Session Agenda
January 23, 2024
10:00 am – 11:00 am

10:00 am Welcome and Chair Statement
Barbara Schneeman, Committee Chair
10:05 am Discussion with Health Canada
  • Stephen Norman, Director, Bureau of Nutritional Sciences, Health Canada
  • Maya Villeneuve, Associate Director, Bureau of Nutritional Sciences, Health Canada
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
  • Mélanie Whiteside, Senior Advisor, Health Canada
11:00 am Adjourn Meeting

D-13: Meeting 24 Public Session Agenda
February 5, 2024
12:00 pm – 1:00 pm ET

12:00 pm Welcome and Chair Statement
Barbara Schneeman, Committee Chair
12:05 pm Preparedness Discussion
  • Nicole Lurie, M.D., M.S.P.H., Former Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services
  • Rear Admiral W. Craig Vanderwagen, M.D., Former Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services
1:00 pm Adjourn Meeting

D-14: Meeting 25 Public Session Agenda
February 5, 2024
2:00 pm – 3:00 pm ET

2:00 pm Welcome and Chair Statement
Barbara Schneeman, Committee Chair
2:05 pm Discussion with David Davis
Moderated by Zoë Neuberger
  • David Davis, Ph.D., Professor, Ness School of Management and Economics, South Dakota State University
3:00 pm Adjourn Meeting

D-15: Meeting 26 Public Session Agenda
February 7, 2024
3:00 pm – 4:00 pm ET

3:00 pm Welcome and Chair Statement
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.

Barbara Schneeman, Committee Chair
3:05 pm Discussion on Infant Formula Supply
  • Laura Modi, Bobbie CEO
4:00 pm Adjourn Meeting
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 327
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 328
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 329
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 330
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 331
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 332
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 333
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 334
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 335
Suggested Citation: "Appendix D: Information-Gathering Public Sessions." National Academies of Sciences, Engineering, and Medicine. 2024. Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States. Washington, DC: The National Academies Press. doi: 10.17226/27765.
Page 336
Next Chapter: Appendix E: Other Committees' Charges Relevant to Infant Formula
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.